[Code of Federal Regulations]
[Title 21, Volume 1]
[Revised as of April 1, 2002]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR5.22]

[Page 34-37]
 
                        TITLE 21--FOOD AND DRUGS
 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN 
                                SERVICES
 
PART 5--DELEGATIONS OF AUTHORITY AND ORGANIZATION--Table of Contents
 
              Subpart B--General Redelegations of Authority
 
Sec. 5.22  Certification of true copies and use of Department seal.

    (a) The following officials are authorized to certify true copies 
of, or extracts from, any books, records, papers, or other documents on 
file within the Food and Drug Administration, to certify that copies are 
true copies of the entire file, to certify the complete original record, 
or to certify the nonexistence of records on file within the Food and 
Drug Administration, and to cause the seal of the Department to be 
affixed to such certifications:
    (1) The Deputy Commissioner, the Senior Associate Commissioner, the 
Deputy Commissioner for International and Constituent Relations, the 
Senior Associate Commissioner for Management and Systems, and the Senior 
Associate Commissioner for Policy, Planning, and Legislation.
    (2) The Associate and Deputy Associate Commissioners and the Chief 
Counsel and Deputy Chief Counsels.
    (3) The Director, Office of the Executive Secretariat, Office of the 
Senior Associate Commissioner, Office of the Commissioner (OC).

[[Page 35]]

    (4) The Director, Office of Executive Operations, Office of the 
Senior Associate Commissioner, OC.
    (5)(i) The Director and Deputy Director, Office of Enforcement, 
Office of Regulatory Affairs (ORA).
    (ii) The Director and Deputy Director, Office of Regional 
Operations, ORA.
    (iii) The Director and Deputy Director, Office of Resource 
Management (ORM), ORA.
    (iv) The Director, Division of Management Operations, ORM, ORA.
    (v) Team Leader, FDA History Staff, ORM, ORA.
    (6)(i) The Director, Office of Human Resources and Management 
Services (OHRMS), Office of Management and Systems (OMS), OC.
    (ii) The Director, Division of Management Programs (DMP), OHRMS, 
OMS, OC.
    (iii) The Chief, Dockets Management Branch, DMP, OHRMS, OMS, OC.
    (7) The Associate Commissioner for Public Affairs, Office of Public 
Affairs (OPA), Office of the Senior Associate Commissioner (OSAC), OC.
    (8)(i) The Chief Information Officer, Office of Information 
Resources Management (OIRM), Office of Management and Systems (OMS), OC.
    (ii) The Director, Freedom of Information Staff, OIRM, OMS, OC.
    (9)(i) The Director and Deputy Directors, Center for Biologics 
Evaluation and Research (CBER).
    (ii) The Director, Office of Management, CBER.
    (iii) The Director and Deputy Directors of the Office of Compliance 
and Biologics Quality, CBER.
    (iv) The Director and Deputy Director, Office of Communication, 
Training, and Manufacturer's Assistance, CBER.
    (v) The Director and Branch Chiefs, Division of Case Management, 
Office of Compliance and Biologics Quality (OCBQ), CBER; and the 
Consumer Safety Officers, OCBQ, CBER.
    (10)(i) The Director and Deputy Director, Center for Food Safety and 
Applied Nutrition (CFSAN).
    (ii) The Director of Regulations and Policy, CFSAN.
    (iii) The Director, Office of Management Systems, CFSAN.
    (iv) The Director, Office of Cosmetics and Colors, CFSAN.
    (v) The Director, Office of Plant and Dairy Foods and Beverages, 
CFSAN.
    (vi) The Director, Office of Seafood, CFSAN.
    (vii) The Director, Office of Nutritional Products, Labeling, and 
Dietary Supplements, CFSAN.
    (viii) The Director, Office of Special Research Skills, CFSAN.
    (ix) The Director, Office of Constituent Operations, CFSAN.
    (x) The Director, Office of Field Programs, CFSAN.
    (xi) The Director, Office of Premarket Approval, CFSAN.
    (xii) The Director, Office of Scientific Analysis and Support, 
CFSAN.
    (11)(i) The Director and Deputy Directors, Center for Devices and 
Radiological Health (CDRH).
    (ii) The Associate Director and Deputy Associate Director for 
Management and Systems, CDRH.
    (iii) The Director and Deputy Director, Office of Compliance, CDRH.
    (iv) For medical devices assigned to their respective divisions, the 
Division Directors, Office of Compliance, CDRH.
    (v) The Director and Deputy Director, Office of Surveillance and 
Biometrics (OSB), CDRH, and the Director and Deputy Director, Division 
of Surveillance Systems (DSS), OSB, CDRH.
    (vi) The Director, Office of Systems and Management, CDRH.
    (vii) Freedom of Information Officers, CDRH.
    (12)(i) The Director and Deputy Director, Center for Veterinary 
Medicine (CVM).
    (ii) The Director and Deputy Director, Office of Management and 
Communications, CVM.
    (iii) The Director and Deputy Director, Office of Surveillance and 
Compliance, CVM.
    (iv) The Director, Division of Compliance, Office of Surveillance 
and Compliance, CVM.
    (13)(i) The Director and Deputy Director for Washington Operations, 
National Center for Toxicological Research (NCTR).
    (ii) The Deputy Center Director, Office of Management (OM), NCTR, 
and the Associate Director, Office of Management Services, OM, NCTR.

[[Page 36]]

    (iii) The Deputy Center Director, Office of Research, NCTR.
    (14)(i) The Director and Deputy Director, the Directors, Office of 
Review Management and Office of Pharmaceutical Science, the Associate 
Director for Regulatory Policy, and the Associate Director for Medical 
Policy, Center for Drug Evaluation and Research (CDER).
    (ii) The Director and Deputy Director, Office of Management, CDER.
    (iii) The Director and Deputy Director, Office of Compliance, CDER.
    (iv) The Directors and Deputy Directors of the Offices of Drug 
Evaluation I, II, III, IV, and V, and the Director and Deputy Director 
of the Office of Biostatistics, Office of Review Management, CDER.
    (v) The Directors and Deputy Directors of the Offices of Testing and 
Research, Generic Drugs, New Drug Chemistry, and Clinical Pharmacology 
and Biopharmaceutics, Office of Pharmaceutical Science, CDER.
    (vi) The Director, Office of Training and Communications (OTCOM), 
and the Director, Division of Information Disclosure Policy, Office of 
Regulatory Policy, CDER.
    (vii) The Directors of the Divisions of Labeling and Non-
prescription Drug Compliance, Prescription Drug Compliance and 
Surveillance, and Manufacturing and Product Quality, Office of 
Compliance, CDER.
    (15)(i) Regional Food and Drug Directors.
    (ii) District Directors.
    (iii) The Director, St. Louis Branch.
    (iv) The Director, Northeast Regional Laboratory, Northeast Region.
    (v) The Director, Southeast Regional Laboratory, Southeast Region.
    (vi) The Director, National Forensic Chemistry Center.
    (vii) The Director, Arkansas Regional Laboratory.
    (viii) The Director, Winchester Engineering Analytical Center.
    (b) The following officials are authorized to cause the seal of the 
Department to be affixed to agreements, awards, citations, diplomas, and 
similar documents:
    (1) Deputy Commissioner; the Senior Associate Commissioner; the 
Deputy Commissioner for International and Constituent Relations; the 
Senior Associate Commissioner for Management and Systems; and the Senior 
Associate Commissioner for Policy, Planning, and Legislation.
    (2) The Associate and Deputy Associate Commissioners and the Chief 
Counsel and Deputies.
    (3) The Director and Deputy Directors, CBER; the Director and Deputy 
Director, CFSAN; the Director and Deputy Directors, CDRH; the Director 
and Deputy Director, CVM; the Director and Deputy Directors, CDER; and 
the Director, NCTR, the Deputy Director for Washington Operations, NCTR, 
and the Deputy Center Directors, Offices of Management and Research, 
respectively, NCTR.
    (4) The Director, Office of Executive Operations, Office of the 
Senior Associate Commissioner (OSAC), OC; Director, Office of 
Management, CBER; Director, Office of Management, CDER; Director, Office 
of Management Systems, CFSAN; Director, Office of Systems and 
Management, CDRH; Director, Office of Management and Communications, 
CVM; Associate Director, Office of Management Services, NCTR; and the 
Director, Office of Resource Management, ORA.
    (5) The Director, Office of Human Resources and Management Services 
(OHRMS), Office of Management and Systems (OMS), OC.
    (c) The following officials may further redelegate the authorities 
under paragraphs (a) and (b) of this section the Deputy Commissioner; 
the Senior Associate Commissioner; the Deputy Commissioner for 
International and Constituent Relations; the Senior Associate 
Commissioner for Management and Systems; the Senior Associate 
Commissioner for Policy, Planning, and Legislation; the Associate and 
Deputy Associate Commissioners; the Chief Counsel and Deputy Chief 
Counsels; the Directors and Deputy Directors for CBER, CFSAN, CDRH, CVM, 
CDER, and NCTR; the Director, Office of Executive Operations, OSAC, OC; 
the Directors of the Offices of Management, CBER and CDER; the Director, 
Office of Management Systems, CFSAN; the Director, Office of Systems and 
Management, CDRH; the Director,

[[Page 37]]

Office of Management and Communications, CVM; the Associate Director, 
Office of Management Services, NCTR; the Director, Office of Resource 
Management, ORA; and the Director, OHRMS, OMS, OC. The other officials 
delegated authority by this section may not further redelegate it.
    (d) The Chief, Regulations Editorial Section (RES), Regulations 
Policy and Management Staff (RPMS), Office of Policy, Planning, and 
Legislation (OPPL), OC, and his or her alternates are authorized to 
certify true copies of Federal Register documents. The Chief, RES, RPMS, 
OPPL, OC may designate alternates as required.